We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$43.7M
(+43%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
33.95%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
223
New
58
Increased
36
Reduced
83
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$6.28M |
| 2 |
Centene
CNC
|
+$3.55M |
| 3 |
Harmony Biosciences
HRMY
|
+$3.07M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
+$2.84M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aurinia Pharmaceuticals
AUPH
|
+$2.42M |
| 2 |
PennyMac Financial
PFSI
|
+$1.76M |
| 3 |
AirSculpt Technologies
AIRS
|
+$1.33M |
| 4 |
Starwood Property Trust
STWD
|
+$1.19M |
| 5 |
Ametek
AME
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.03% |
| 2 | Real Estate | 10.47% |
| 3 | Financials | 4.37% |
| 4 | Energy | 4.28% |
| 5 | Technology | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Coca-Cola
KO
$353B
| $241K | 0.17% |
3,892
-71
| -2% | -$4.3K |
|
127
Bristol-Myers Squibb
BMY
$123B
| $241K | 0.17% |
3,479
-39
| -1% | -$2.75K |
|
|
K
128
DELISTED
Kellanova
K
| $237K | 0.16% |
3,776
-36
| -0.9% | -$2.27K |
|
129
Amgen
AMGN
$197B
| $237K | 0.16% |
982
-10
| -1% | -$2.46K |
|
130
Archer Daniels Midland
ADM
$41.3B
| $237K | 0.16% |
2,971
-132
| -4% | -$10.8K |
|
131
W.R. Berkley
WRB
$27.1B
| $236K | 0.16% |
5,685
-57
| -1% | -$2.55K |
|
132
Chevron
CVX
$378B
| $229K | 0.16% |
1,404
-59
| -4% | -$9.89K |
|
133
Jack Henry & Associates
JKHY
$10.9B
| $227K | 0.16% |
1,504
-28
| -2% | -$4.67K |
|
134
iShares US & Intl High Yield Corp Bond ETF
GHYG
$185M
| $226K | 0.16% |
+5,278
| New | +$223K |
|
|
VRAY
135
DELISTED
ViewRay, Inc.
VRAY
| $225K | 0.16% |
+65,000
| New | +$275K |
|
136
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $223K | 0.15% |
+5,356
| New | +$222K |
|
137
Amylyx Pharmaceuticals
AMLX
$1.94B
| $220K | 0.15% |
+7,500
| New | +$261K |
|
138
American International
AIG
$42.3B
| $219K | 0.15% |
4,351
-196
| -4% | -$11.4K |
|
139
Microbot Medical
MBOT
$120M
| $208K | 0.14% |
100,000
| – | – |
|
140
EQT Corp
EQT
$30.7B
| $208K | 0.14% |
6,513
-304
| -4% | -$9.75K |
|
141
HF Sinclair
DINO
$16.3B
| $206K | 0.14% |
4,265
-229
| -5% | -$11.9K |
|
142
Nano X Imaging
NNOX
$77.3M
| $202K | 0.14% |
+35,000
| New | +$268K |
|
|
MMD
143
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$287M
| $195K | 0.13% |
11,242
-14,758
| -57% | -$257K |
|
144
CF Industries
CF
$19B
| $171K | 0.12% |
2,355
-113
| -5% | -$9.24K |
|
145
iShares MSCI Peru and Global Exposure ETF
EPU
$528M
| $168K | 0.12% |
+5,527
| New | +$166K |
|
146
iShares MSCI Mexico ETF
EWW
$1.88B
| $166K | 0.11% |
+2,785
| New | +$159K |
|
147
iShares MSCI Chile ETF
ECH
$1.01B
| $164K | 0.11% |
+5,710
| New | +$161K |
|
148
iShares Fallen Angels USD Bond ETF
FALN
$1.64B
| $160K | 0.11% |
+6,329
| New | +$159K |
|
149
Steel Dynamics
STLD
$33.2B
| $160K | 0.11% |
1,413
-70
| -5% | -$8.14K |
|
150
Teck Resources
TECK
$26.7B
| $154K | 0.11% |
4,208
-212
| -5% | -$8.41K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, AlphaCentric Advisors held 223 positions worth $145M, up 43% from $101M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AlphaCentric Advisors deployed $49.2M of net new capital in Q1 2023, opening 58 new positions and adding to 36 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 57% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Aurinia Pharmaceuticals, an estimated $2.42M trimmed.
- AlphaCentric Advisors's largest Q1 2023 buy was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
- AlphaCentric Advisors added most to BioCryst Pharmaceuticals in Q1 2023, an estimated $2.84M increase.
- AlphaCentric Advisors's biggest Q1 2023 reduction was Aurinia Pharmaceuticals, cutting an estimated $2.42M.
- AlphaCentric Advisors fully exited PennyMac Financial in Q1 2023, selling an estimated $1.76M.
- AlphaCentric Advisors's ten largest holdings make up 24% of its $145M portfolio in Q1 2023.
- AlphaCentric Advisors opened 58 new positions and closed 14 in Q1 2023.
- AlphaCentric Advisors's portfolio value rose 43% quarter-over-quarter to $145M.
Based on AlphaCentric Advisors's 13F filing for Q1 2023, filed 12 May 2023.